One Patient And Drug Management Solution For A Critical Oncology Trial For Pancreatic Cancer

A leading biotechnology firm with a reputation for delivering quality solutions was tasked with conducting a groundbreaking multicenter study evaluating the safety and efficacy of a new oncology drug in patients with pancreatic cancer. Due to the critical nature of this trial, they had high expectations and demanded exceptional results–efficient drug and patient management, seamless communications among participants and clinicians, and strict adherence to timelines–yet they were concerned about meeting target timelines due to the growing complexities of the trial. After initially working with another IRT vendor who failed to meet their needs, they came to Cenduit to rescue the trial.